Treatment of Exercise-induced Laryngomalacia in Elite Athletes

Exercise-induced Laryngomalacia Clinical Trial

— EIL  

Official title:

Treatment of Exercise-induced Laryngo Obstruction in Elite Athletes

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT00520624
• Other study ID #: PC-EIL-07-ELITE
• Status: Withdrawn
• Phase: N/A
• Start date: January 2013
• Est. completion date: January 2020

Study information

• Verified date: January 2021
• Source: Bispebjerg Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Treatment of exercise-induced laryngomalacia (an obstruction of larynx during physical activity) in elite athletes using two different treatments. The study is randomized with control groups.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: January 2020
• Est. primary completion date: January 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years and older

Eligibility

Inclusion Criteria:

• Laryngoscopically verified EIL,
• Elite athlete for a minimum of 1 year and continuing for a minimum 6 months after start of treatment

Exclusion Criteria:

• Has to be able to run on treadmill

Related Conditions & MeSH terms

• Exercise-induced Laryngomalacia
• Laryngomalacia

Intervention

Device:
• inspiratory muscle strength training

Procedure:
• Surgery

Locations

Country	Name	City	State
Denmark	Bispebjerg Hospital, Lungemedicinsk Forskningsenhed	Copenhagen

Sponsors (2)

Lead Sponsor	Collaborator
Bispebjerg Hospital	Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark,